Amazon launches AI research tool to speed early-stage drug discovery
This image was generated by AI and may not depict real events.
Amazon has launched Amazon Bio Discovery, an AI research tool designed to speed up early-stage drug discovery. The tool allows scientists to run complex computational workflows without writing code and has already been adopted by several major pharmaceutical companies.
Amazon's cloud unit has launched Amazon Bio Discovery, an AI application for early-stage drug discovery. The tool gives researchers access to a library of biological foundation models and an AI agent to select models and interpret results. Researchers can send candidates to lab partners for synthesis and testing, with results routed back into the system. The platform has already been used in a collaboration with Memorial Sloan Kettering Cancer Center to generate novel antibody molecules. Amazon Bio Discovery is intended to augment scientists and contract research organizations, not replace them. The tool has been adopted by several major pharmaceutical companies, including Bayer and Voyager Therapeutics.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.